CLINICAL_TRIALS
trial_result
· 2018-08-07
Clinical Trial Update: OPTIMA: An Observational Study of Mircera (Methoxy Polyethylene Glycol-Epoetin Beta) in Participants With Chronic Kidney Disease Stages 3 and 4 Not on Dialysis
Summary
Observational study of Mircera in CKD patients not on dialysis has completed with results posted in 2018.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Hoffmann-La Roche | Conditions: Anemia | Status: COMPLETED | Results posted: 2018-08-07